Stockreport

Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF for the treatment of neurological disorders, today announced it is preparing to undertake the final steps of GMP manufacturing and formulation of its drug candidate for [Read more]